Related Experiment Video
Updated: Feb 5, 2026

Isolation of Cancer Stem Cells From Human Prostate Cancer Samples
Published on: March 14, 2014
SPOP suppresses prostate cancer through regulation of CYCLIN E1 stability
Lin-Gao Ju1, Yuan Zhu2, Qiao-Yun Long1
1Hubei Key Laboratory of Cell Homeostasis, Hubei Key Laboratory of Developmentally Originated Disease, College of Life Sciences, Wuhan University, Wuhan, Hubei, 430072, China.
Abstract:
SPOP is one of the important subunits for CUL3/SPOP/RBX1 complex tightly connected with tumorigenesis. However, its exact roles in different cancers remain debatable. Here, we identify CYCLIN E1, as a novel substrate for SPOP. SPOP directly interacts with CYCLIN E1 and specific regulates its stability in prostate cancer cell lines. SPOP/CUL3/RBX1 complex regulates CYCLIN E1 stability through poly-ubiquitination. CDK2 competes with SPOP for CYCLIN E1 interaction, suggesting that SPOP probably regulates the stability of CDK2-free CYCLIN E1. CYCLIN E1 expression rescued proliferation, migration, and tumor formation of prostate cancer cell suppressed by SPOP. Furthermore, we found SPOP selectively regulates the substrates' stability and signaling pathways in prostate cancer and CCRC cell lines, suggesting that complicated mechanisms exist for SPOP to regulate substrate specificity. Altogether, we have revealed a novel mechanism for SPOP in suppressing prostate cancer and provided evidence to show SPOP has dual functions in prostate cancer and CCRC.
Insights
Suppressor of Propargyl Pathway (SPOP) targets CYCLIN E1 for degradation in prostate cancer. This discovery reveals a new mechanism for SPOP in suppressing tumor growth and highlights its dual role in cancer.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- The CUL3/SPOP/RBX1 complex is implicated in tumorigenesis, but SPOP's specific roles in various cancers are unclear.
- Understanding SPOP's substrate specificity is crucial for elucidating its function in cancer.
Purpose of the Study:
- To identify novel substrates of SPOP.
- To investigate the role of SPOP in regulating CYCLIN E1 stability and function in prostate cancer.
- To explore the substrate specificity of SPOP in different cancer types.
Main Methods:
- Co-immunoprecipitation assays to confirm SPOP-CYCLIN E1 interaction.
- Ubiquitination assays to demonstrate SPOP-mediated poly-ubiquitination of CYCLIN E1.
- Cell proliferation, migration, and tumor formation assays in prostate cancer cell lines.
- Western blotting to assess protein stability and signaling pathway modulation.
Main Results:
- CYCLIN E1 was identified as a novel substrate directly interacting with SPOP.
- SPOP, via the SPOP/CUL3/RBX1 complex, promotes poly-ubiquitination and degradation of CYCLIN E1 in prostate cancer cells.
- CDK2 competes with SPOP for CYCLIN E1 binding, suggesting regulation of CDK2-free CYCLIN E1.
- Restoration of CYCLIN E1 expression reversed SPOP-mediated suppression of proliferation, migration, and tumor formation.
- SPOP exhibits selective substrate regulation in prostate cancer and colorectal cancer (CRC) cell lines.
Conclusions:
- SPOP suppresses prostate cancer progression by targeting CYCLIN E1 for degradation.
- The interaction between SPOP and CYCLIN E1, regulated by CDK2, represents a novel mechanism in prostate cancer.
- SPOP demonstrates dual functions in prostate cancer and colorectal cancer, indicating complex regulatory mechanisms for substrate specificity.
Related Concept Videos
Positive Regulator Molecules
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Negative Regulator Molecules
E1 Reaction: Kinetics and Mechanism
E1 Reaction: Stereochemistry and Regiochemistry
Nuclear Stability
To hold positively charged protons together...

